EP 1051169 A4 20020529 - COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES
Title (en)
COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRUS INFECTION AND ASSOCIATED DISEASES
Title (de)
VERBINDUNGEN, ZUSAMMENSTELLUNGEN UND METHODEN ZUR BEHANDLUNG VON PNEUMOVIRALEN INFEKTIONEN UND DAMIT VERBUNDENE KRANKHEITEN
Title (fr)
COMPOSES, COMPOSITIONS ET METHODES DE TRAITEMENT OU DE PREVENTION D'INFECTIONS PNEUMOVIRALES ET DE MALADIES ASSOCIEES
Publication
Application
Priority
- US 9901985 W 19990129
- US 7303898 P 19980129
- US 7307898 P 19980130
Abstract (en)
[origin: WO9938508A1] Compounds, compositions and methods are provided for the prophylaxis and treatment of infections caused by viruses of the Pneumovirinae subfamily of Paramyxoviridae and diseases associated with such infections.
IPC 1-7
C07D 257/06; A61K 31/41; C07D 249/14; C07D 257/04; C07D 277/24; C07D 261/08; C07D 401/10; C07D 233/54; A61K 31/415; A61K 31/42; A61K 31/425
IPC 8 full level
C07D 249/08 (2006.01); A61K 31/33 (2006.01); A61K 31/34 (2006.01); A61K 31/341 (2006.01); A61K 31/38 (2006.01); A61K 31/381 (2006.01); A61K 31/395 (2006.01); A61K 31/40 (2006.01); A61K 31/41 (2006.01); A61K 31/42 (2006.01); A61K 31/421 (2006.01); A61K 31/426 (2006.01); A61K 31/435 (2006.01); A61P 31/12 (2006.01); C07D 207/30 (2006.01); C07D 207/32 (2006.01); C07D 207/323 (2006.01); C07D 207/33 (2006.01); C07D 207/335 (2006.01); C07D 213/74 (2006.01); C07D 233/56 (2006.01); C07D 233/61 (2006.01); C07D 249/14 (2006.01); C07D 257/04 (2006.01); C07D 257/06 (2006.01); C07D 261/06 (2006.01); C07D 261/08 (2006.01); C07D 261/14 (2006.01); C07D 263/30 (2006.01); C07D 263/32 (2006.01); C07D 263/34 (2006.01); C07D 263/48 (2006.01); C07D 277/24 (2006.01); C07D 277/28 (2006.01); C07D 307/34 (2006.01); C07D 307/36 (2006.01); C07D 307/40 (2006.01); C07D 307/52 (2006.01); C07D 333/02 (2006.01); C07D 333/06 (2006.01); C07D 333/10 (2006.01); C07D 333/20 (2006.01); C07D 413/10 (2006.01); C07D 417/10 (2006.01); C09B 11/04 (2006.01)
CPC (source: EP)
A61P 31/12 (2017.12); C07D 249/14 (2013.01); C07D 257/04 (2013.01); C07D 257/06 (2013.01); C07D 261/08 (2013.01); C07D 277/24 (2013.01)
Citation (search report)
- [X] US 5098920 A 19920324 - REITZ DAVID B [US]
- [X] GB 1508391 A 19780426 - STERLING DRUG INC
- [X] WO 9500131 A1 19950105 - CAMBRIDGE NEUROSCIENCE INC [US], et al
- [A] EP 0795549 A1 19970917 - AMERICAN CYANAMID CO [US]
- [A] US 4324794 A 19820413 - TIDWELL RICHARD R, et al
- [X] SCHLEGEL, DONALD C. ET AL: "Bulky amine analogs of ketoprofen: potent antiinflammatory agents", J. MED. CHEM. (1984), 27(12), 1682-90, XP000973055
- [X] BAKER, B.R. ET AL: "Irreversible Enzyme Inhibitors. 181. Inhibition of Brain Choline Acetyltransferase by Derivatives of 4-Stilbazole", J. MED. CHEM., 1984, pages 315 - 322, XP000938518
- [A] DE CLERCQ, ERIK: "Perspectives for the chemotherapy of respiratory syncytial virus (RSV) infections", INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, vol. 7, 1996, pages 193 - 202, XP002193685
- See references of WO 9938508A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9938508 A1 19990805; AU 759772 B2 20030501; BR 9908522 A 20011002; CA 2319465 A1 19990805; CA 2319465 C 20130319; CN 1289248 A 20010328; EP 1051169 A1 20001115; EP 1051169 A4 20020529; JP 2002501894 A 20020122; MX PA00007394 A 20030801; NZ 505894 A 20021220
DOCDB simple family (application)
US 9901985 W 19990129; AU 2568599 A 19990129; BR 9908522 A 19990129; CA 2319465 A 19990129; CN 99802500 A 19990129; EP 99905546 A 19990129; JP 2000529241 A 19990129; MX PA00007394 A 19990129; NZ 50589499 A 19990129